Tag: Cancer: Leukemia
Progression-Free Survival Increased With Zanubrutinib in Leukemia
Longer progression-free survival seen with zanubrutinib versus ibrutinib for patients with relapsed or refractory chronic or small lymphocytic leukemia
Patient-Centered Communication Tool Feasible for Seniors With Acute Myeloid Leukemia
Patients, caregivers scored higher on AML knowledge and perceived greater efficacy in communicating with oncologists
Single-Tube Multiparametric Flow Cytometry Predicts Treatment Response in Leukemia
Multiparametric flow cytometry has excellent prediction for survival among patients with B-cell acute lymphoblastic leukemia
Adherence to Quality Indicators Low in Chronic Myeloid Leukemia
Compliance with diagnostic and therapeutic indicators was 83 and 78 percent, while compliance with monitoring indicators was lower
Polypharmacy Prevalent Among Older Adults With Blood Cancers
Taking eight or more medications strongly associated with frailty; odds of being prefrail, frail increased with each additional med
Higher Tisagenlecleucel Doses May Improve Outcomes in Youth With B-ALL
Overall, event-free, relapse-free survival improved in patients receiving higher doses of tisagenlecleucel, with no increased toxicity
Air Pollution May Increase Risk for Childhood Leukemia
Strongest association seen for benzene exposure and acute myeloid leukemia
Dual Effect Identified for Arsenic in Carcinogenesis
Arsenic level in drinking water negatively associated with incidences of lymphoma, leukemia in men and women
Long-Term Mortality Rates Elevated for Adolescent, Young Adult Leukemia Survivors
Survival for adolescent and young adult leukemia survivors remained below general population at up to 30 years of follow-up
